Socialpost

Complete News World

Moderna-Booster is working against the Omikron variant «kleinezeitung.at

Moderna-Booster is working against the Omikron variant «kleinezeitung.at

Data from the first study show the effect of booster vaccination with a recent vaccine against the Omicron variant of the Coronavirus.

1:32 pm, December 20, 2021

×

The article is marked

You can always find the selected articles in your reading list
Re-Call. You can access your reading list directly by navigating the page.

to the reading list

© Lutsenko Oleksandr

the Moderna covid vaccine According to the study Three cans May still be effective against rapid expansion Variable Omicron. The US biotech company announced Monday that a booster dose of the vaccine is the first defense in the battle against Omikron.

At the same time, the company also continues to work on one Customized Vaccine. “In order to respond to this highly transferable variant, Moderna will continue to advance the development of an omicron-specific enhanced filter and rapidly introduce it into the clinical testing phase, should it become necessary in the future.”CEO Stefan Bancel said:

Preliminary lab data from the company indicated that double vaccination with Moderna produced low levels of omicron-neutralizing antibodies. The 50 mcg booster dose increased the omicron-neutralizing antibody level approximately 37 times, and the 100 mcg booster dose up to about 83 times. In Austria, 50 mcg is vaccinated because 100 mcg sometimes leads to strong vaccination reactions.

In October, the US authorities 50 mcg boost of the approved vaccine. The dose for the first two vaccines of Moderna is 100 mcg each. Burton said governments and regulators should consider whether they want the increased protection provided by a 100 microgram booster. The higher dose is generally considered safe and well tolerated, but it tends to have somewhat more frequent side effects.

Moderna and Biontech/Pfizer’s mRNA vaccines are included Rare cases of myocarditisEspecially in young people. Several studies indicate that Moderna may cause a higher rate of myocarditis. In many countries, including Germany, the vaccine is no longer used for people under 30 years old.

Biontech reported on the efficacy of its vaccine against the Omikron variant that two doses had a significantly lower neutralization titer against the new variant. However, a booster dose can increase the neutralizing antibody titer by 25 times compared to two doses. Biontech and Pfizer are already working on a modified vaccine against Omikron and we expect it to be available by the end of March.

See also  Trump wanted to officially declare the US election "corrupt"